STOCK TITAN

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

The Oncology Institute (NASDAQ: TOI) announced it will release its Q3 2024 financial results after market close on November 13, 2024, followed by a conference call at 5:00 p.m. Eastern Time. Investors can access the call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available until November 20, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international) using passcode 13749308. A simultaneous webcast will be available on TOI's Investor Relations website.

L'Istituto di Oncologia (NASDAQ: TOI) ha annunciato che pubblicherà i risultati finanziari del terzo trimestre del 2024 dopo la chiusura del mercato il 13 novembre 2024, seguiti da una conferenza telefonica alle 17:00 ora orientale. Gli investitori possono partecipare alla chiamata componendo il numero 1-877-407-0789 (USA) o 1-201-689-8562 (internazionale). Una registrazione sarà disponibile fino al 20 novembre 2024, accessibile tramite 1-844-512-2921 (USA) o 1-412-317-6671 (internazionale) utilizzando il codice di accesso 13749308. Un webcast simultaneo sarà disponibile sul sito web delle Relazioni con gli Investitori di TOI.

El Instituto de Oncología (NASDAQ: TOI) anunció que publicará sus resultados financieros del tercer trimestre de 2024 al cierre del mercado el 13 de noviembre de 2024, seguido de una conferencia telefónica a las 5:00 p.m. Hora del Este. Los inversores pueden acceder a la llamada marcando el 1-877-407-0789 (EE. UU.) o el 1-201-689-8562 (internacional). Se dispondrá de una grabación hasta el 20 de noviembre de 2024, accesible a través del 1-844-512-2921 (EE. UU.) o el 1-412-317-6671 (internacional) usando el código de acceso 13749308. Se ofrecerá una transmisión web simultánea en el sitio web de Relaciones con Inversores de TOI.

종양학 연구소(NASDAQ: TOI)는 2024년 3분기 재무 결과2024년 11월 13일 시장 종료 후 발표한다고 발표했으며, 동부 표준시 기준 오후 5시에 컨퍼런스 콜이 이어질 것입니다. 투자자는 1-877-407-0789 (미국) 또는 1-201-689-8562 (국제)로 전화를 걸어 콜에 참여할 수 있습니다. 재생은 2024년 11월 20일까지 제공되며, 1-844-512-2921 (미국) 또는 1-412-317-6671 (국제)로 접근할 수 있으며, 접속코드는 13749308입니다. TOI의 투자자 관계 웹사이트에서 동시에 웹캐스트가 진행될 예정입니다.

L'Institut d'Oncologie (NASDAQ: TOI) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le 13 novembre 2024, suivi d'un appel conférence à 17h00 heure de l'Est. Les investisseurs peuvent accéder à l'appel en composant le 1-877-407-0789 (États-Unis) ou le 1-201-689-8562 (international). Un replay sera disponible jusqu'au 20 novembre 2024, accessible via le 1-844-512-2921 (États-Unis) ou le 1-412-317-6671 (international) en utilisant le code d'accès 13749308. Un webinaire simultané sera disponible sur le site Internet des Relations Investisseurs de TOI.

Das Onkologie-Institut (NASDAQ: TOI) gab bekannt, dass es seine Finanz Ergebnisse für das 3. Quartal 2024 nach dem Marktende am 13. November 2024 bekannt geben wird, gefolgt von einer Telefonkonferenz um 17:00 Uhr Eastern Time. Investoren können an dem Anruf teilnehmen, indem sie 1-877-407-0789 (USA) oder 1-201-689-8562 (international) wählen. Eine Aufzeichnung wird bis zum 20. November 2024 verfügbar sein, erreichbar unter 1-844-512-2921 (USA) oder 1-412-317-6671 (international) mit dem Zugangscode 13749308. Ein Webcast wird gleichzeitig auf der Investor-Relations-Website von TOI zur Verfügung stehen.

Positive
  • None.
Negative
  • None.

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13749308. The replay will be available until Wednesday, November 20, 2024.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors

Solebury Strategic Communications
investors@theoncologyinstitute.com


FAQ

When will TOI release its Q3 2024 earnings?

The Oncology Institute (TOI) will release its Q3 2024 earnings after market close on Wednesday, November 13, 2024.

What time is TOI's Q3 2024 earnings conference call?

TOI's Q3 2024 earnings conference call is scheduled for 5:00 p.m. Eastern Time on Wednesday, November 13, 2024.

How can investors access TOI's Q3 2024 earnings call replay?

Investors can access the replay until November 20, 2024, by dialing 1-844-512-2921 (US) or 1-412-317-6671 (international) with passcode 13749308.

The Oncology Institute, Inc.

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Stock Data

21.14M
75.49M
19.56%
45.35%
0.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
CERRITOS